APA

van Zweeden A. A., van Groeningen C. J., Honeywell R. J., Giovannetti E., Ruijter R., Smorenburg C. H., Giaccone G., Verheul H. M. W., Peters G. J. & van der Vliet H. J. (20190625). Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer. : Cancer chemotherapy and pharmacology.

Chicago

van Zweeden A A, van Groeningen C J, Honeywell R J, Giovannetti E, Ruijter R, Smorenburg C H, Giaccone G, Verheul H M W, Peters G J and van der Vliet Hans J. 20190625. Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer. : Cancer chemotherapy and pharmacology.

Harvard

van Zweeden A. A., van Groeningen C. J., Honeywell R. J., Giovannetti E., Ruijter R., Smorenburg C. H., Giaccone G., Verheul H. M. W., Peters G. J. and van der Vliet H. J. (20190625). Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer. : Cancer chemotherapy and pharmacology.

MLA

van Zweeden A A, van Groeningen C J, Honeywell R J, Giovannetti E, Ruijter R, Smorenburg C H, Giaccone G, Verheul H M W, Peters G J and van der Vliet Hans J. Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer. : Cancer chemotherapy and pharmacology. 20190625.